A pharmaceutical composition for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier providing a delivered dose of aclidinium equivalent to about 322 micrograms aclidinium free base.